VOR — Vor Biopharma Balance Sheet
0.000.00%
Last trade - 00:00- $116.65m
- -$20.53m
- 13
- 38
- 23
- 14
Annual balance sheet for Vor Biopharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 6.47 | 48.5 | 207 | 230 | 137 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 7.54 | 49.1 | 214 | 237 | 141 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.728 | 21.8 | 22.5 | 57.1 | 50.1 |
| Other Long Term Assets | |||||
| Total Assets | 9.83 | 75.9 | 243 | 299 | 198 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2.19 | 10.2 | 10.2 | 13.1 | 15.6 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 2.19 | 27.6 | 26.3 | 48.8 | 47.4 |
| Redeemable Preferred Stock | |||||
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Total Equity | 7.64 | 48.3 | 216 | 251 | 151 |
| Total Liabilities & Shareholders' Equity | 9.83 | 75.9 | 243 | 299 | 198 |
| Total Common Shares Outstanding |